Neuroblastoma

Neuroblastoma is a cancer that often begins in childhood. It impacts the nerve tissue, especially in the adrenal glands.

Programs + Services


Hematology/Oncology

The Division of Pediatric Hematology/Oncology at Floating Hospital for Children in Boston provides treatment for children with cancer and blood disorders.
More information about programs and services


Neurosurgery

Floating Hospital for Children's Pediatric Neurosurgery Division in Boston uses the latest neurosurgical methods to treat diseases of the nervous system in children.
More information about programs and services


Blood and Marrow Transplant Program

The Blood and Marrow Transplant Program at Floating Hospital in Boston provides hematopoietic cell transplants for children with cancer and blood disorders.
More information about programs and services

Doctors + Care Team

Jason Law, MD

Jason Law, MD

Accepting New Patients

Title(s): Interim Chief, Pediatric Hematology Oncology; Site Principal Investigator, Children’s Oncology Group and Neuroblastoma Medulloblastoma Translational Research Consortium Trials; Director, Pediatric Bone Marrow Transplantation; Assistant Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Pediatric hematology, oncology, bone marrow transplant

View Full Profile for Jason Law, MD

Carl B. Heilman, MD

Carl B. Heilman, MD

Accepting New Patients

Title(s): Neurosurgeon-in-Chief; Chairman of Neurosurgery; Professor, Tufts University School of Medicine
Department(s): Neurosurgery
Appt. Phone: 617-636-5860
Fax #: 617-636-7587

Meningiomas, acoustic neuromas, skull base surgery, pituitary surgery, Chiari surgery

View Full Profile for Carl B. Heilman, MD

Michael Kelly, MD, MPH, MS

Michael Kelly, MD, MPH, MS

Title(s): Associate Clinical Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Hematology/Oncology
Appt. Phone: 617-636-5535
Fax #: 617-636-7738

Childhood cancers including leukemia, lymphoma and solid tumors, anemia and bleeding disorders, thrombosis

View Full Profile for Michael Kelly, MD, MPH, MS

Susan K. Parsons, MD, MRP

Susan K. Parsons, MD, MRP

Accepting New Patients

Title(s): Founding Director, Reid R. Sacco Adolescent and Young Adult Program for Cancer and Hereditary Blood Diseases; Director, The Center for Health Solutions at the Institute for Clinical Research and Health Policy Studies; Professor, Tufts University School of Medicine
Department(s): Pediatrics, Cancer Center, Medicine, Pediatric Hematology/Oncology, Hematology/Oncology
Appt. Phone: 617-636-5168
Fax #: 617-636-6280

Pediatric bone marrow transplantation, long-term quality of life following transplantation, supportive medical and emotional care for patients and families

View Full Profile for Susan K. Parsons, MD, MRP

Research + Clinical Trials


A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma

This study is being done to test the effect of a drug, nifurtimox, against neuroblastoma and medulloblastoma in children. Nifurtimox is a drug that has been used in South America for many years to treat a parasitic disease known as Chagas Disease. It is not approved by the Food and Drug Administration for routine use in neuroblastoma or medulloblastoma in the United States, but the FDA is allowing it to be used in research studies like this one. Limited early observations, suggest that nifurtimox may have anti-tumor activity for neuroblastoma and medulloblastoma. We do not know whether nifurtimox will shrink/kill tumor cells effectively in children. Therefore, the major goal of the study is to learn if nifurtimox in combination with other common chemotherapy drugs is effective in shrinking/killing neuroblastoma and medulloblastoma cells. We will also be collecting information about any side effects that the drug may have.
More information about research and clinical trials